These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


667 related items for PubMed ID: 10741381

  • 1. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H, Ota M, Kobayashi M, Kaneko H, Kasahara Y, Nishimura S, Kondo S, Komoriya K.
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
    [Abstract] [Full Text] [Related]

  • 2. Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents.
    Osada Y, Tsuchimoto M, Fukushima H, Takahashi K, Kondo S, Hasegawa M, Komoriya K.
    Eur J Pharmacol; 1993 Sep 14; 241(2-3):183-8. PubMed ID: 8243554
    [Abstract] [Full Text] [Related]

  • 3. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
    Zhao X, Zhu JX, Mo SF, Pan Y, Kong LD.
    J Ethnopharmacol; 2006 Feb 20; 103(3):357-65. PubMed ID: 16182482
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens.
    Carro MD, Falkenstein E, Radke WJ, Klandorf H.
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan 20; 151(1):12-7. PubMed ID: 19654053
    [Abstract] [Full Text] [Related]

  • 6. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
    Ka T, Moriwaki Y, Inokuchi T, Yamamoto A, Takahashi S, Tsutsumi Z, Yamamoto T.
    Horm Metab Res; 2006 Mar 20; 38(3):188-92. PubMed ID: 16673211
    [Abstract] [Full Text] [Related]

  • 7. Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity.
    Kong L, Zhou J, Wen Y, Li J, Cheng CH.
    Planta Med; 2002 Feb 20; 68(2):175-8. PubMed ID: 11859475
    [Abstract] [Full Text] [Related]

  • 8. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
    Zhu JX, Wang Y, Kong LD, Yang C, Zhang X.
    J Ethnopharmacol; 2004 Jul 20; 93(1):133-40. PubMed ID: 15182918
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics/pharmacodynamics of Y-700, a novel xanthine oxidase inhibitor, in rats and man.
    Yamada I, Fukunari A, Osajima T, Kamezawa M, Mori H, Iwane J.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct 20; 23(8-9):1123-5. PubMed ID: 15571214
    [Abstract] [Full Text] [Related]

  • 10. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice.
    Kong LD, Yang C, Ge F, Wang HD, Guo YS.
    J Ethnopharmacol; 2004 Aug 20; 93(2-3):325-30. PubMed ID: 15234772
    [Abstract] [Full Text] [Related]

  • 11. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan 20; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 12. Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats.
    Yamamoto Y, Ogino K, Igawa G, Matsuura T, Kaetsu Y, Sugihara S, Matsubara K, Miake J, Hamada T, Yoshida A, Igawa O, Yamamoto T, Shigemasa C, Hisatome I.
    Hypertens Res; 2006 Nov 20; 29(11):915-21. PubMed ID: 17345792
    [Abstract] [Full Text] [Related]

  • 13. Nephrotoxic effects of allopurinol in dinitrofluorobenzene-sensitized mice: comparative studies on TEI-6720.
    Horiuchi H, Ota M, Kaneko H, Kasahara Y, Ohta T, Komoriya K.
    Res Commun Mol Pathol Pharmacol; 1999 Nov 20; 104(3):293-305. PubMed ID: 10741380
    [Abstract] [Full Text] [Related]

  • 14. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
    Rebentisch G, Stolz S, Muche J.
    Aktuelle Urol; 2004 Jun 20; 35(3):215-21. PubMed ID: 15258855
    [Abstract] [Full Text] [Related]

  • 15. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD, Bertram JF, Ryan GB.
    Exp Nephrol; 1995 Jun 20; 3(5):270-9. PubMed ID: 7583048
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ, Prior C, Puig JG.
    Metabolism; 2007 Sep 20; 56(9):1179-86. PubMed ID: 17697859
    [Abstract] [Full Text] [Related]

  • 18. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
    Minami M, Ishiyama A, Takagi M, Omata M, Atarashi K.
    Blood Press; 2005 Sep 20; 14(2):120-5. PubMed ID: 16036490
    [Abstract] [Full Text] [Related]

  • 19. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers.
    Becker MA, Kisicki J, Khosravan R, Wu J, Mulford D, Hunt B, MacDonald P, Joseph-Ridge N.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct 20; 23(8-9):1111-6. PubMed ID: 15571211
    [Abstract] [Full Text] [Related]

  • 20. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
    Takano Y, Hase-Aoki K, Horiuchi H, Zhao L, Kasahara Y, Kondo S, Becker MA.
    Life Sci; 2005 Mar 04; 76(16):1835-47. PubMed ID: 15698861
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.